How to Qualify a Chinese Medical Device Manufacturer for the EU Market Under the MDR
Chinese medical device manufacturers offer many attractive products for European distributors, importers and other EU stakeholders. The combination of competitive pricing, manufacturing capacity and increasingly sophisticated technologies can create interesting opportunities.
However, qualifying a Chinese manufacturer for the EU market is not simply a matter of asking for a CE certificate.
We regularly see European companies struggling to determine whether a product is actually a medical device under the EU Medical Device Regulation (MDR), whether the claimed conformity assessment is valid, whether the product corresponds to the technical documentation, and whether the Chinese partner can reliably fulfil its regulatory and quality responsibilities.
This article focuses primarily on medical devices under Regulation (EU) 2017/745 (MDR) and provides a practical qualification approach for Chinese manufacturers.
The central principle is simple:
Do not qualify the certificate. Qualify the manufacturer, the device and the entire regulatory evidence package.
1. Start with the legal manufacturer
The first question should be:
Who is the legal manufacturer of the device?
This sounds straightforward, but in practice the company communicating with you may be a trading company, factory, OEM, brand owner, or another intermediary. These roles are not necessarily the same.
For an EU market entry project, you should establish the exact legal entity that assumes the manufacturer responsibilities under the MDR.
For a manufacturer established outside the EU, the MDR requires a sole authorised representative in the European Union. The authorised representative has defined regulatory responsibilities under Article 11 and is not simply a postal address or commercial contact.
Check EUDAMED
EUDAMED should be one of the first verification points.
As of 28 May 2026, the first four EUDAMED modules became mandatory to use, including:
- Actor Registration
- UDI/Device Registration
- Notified Bodies & Certificates
- Market Surveillance
The Actor Registration module provides the economic operator with a Single Registration Number (SRN). Non-EU manufacturers must have an active authorised representative and provide the relevant mandate information when registering.
A claim such as "We already have MDR products" should be treated as a statement to be verified, not as evidence of compliance.
2. Check the CE conformity documentation
The next step is to determine what conformity assessment has actually been performed.
Every MDR device subject to CE marking needs an appropriate conformity assessment and an EU Declaration of Conformity (DoC). The DoC must contain the information required by the MDR, including identification of the manufacturer and device and the applicable legislation and conformity assessment route.
But the DoC alone does not tell the whole story.
For devices where a notified body is required, you should also identify the relevant notified-body certificate and verify its status.
The terminology is important here. Under the MDR, it is better not to use the old general expression "EC certificate". Depending on the conformity assessment procedure, the manufacturer may have, for example, an EU quality management system certificate or an EU technical documentation assessment certificate.
Verify the certificate independently
Ask the manufacturer to provide:
- the current EU Declaration of Conformity;
- all relevant notified-body certificates;
- the notified body's name and identification number;
- certificate numbers;
- certificate scope;
- covered device families/models;
- validity dates;
- any relevant amendments, supplements, suspensions or restrictions.
Then verify the information independently.
Since 28 May 2026, the EUDAMED Notified Bodies & Certificates module is mandatory and provides public information concerning certificates registered by notified bodies, including certificates that have been amended, suspended, reinstated or withdrawn.
For a critical qualification project, it is also sensible to verify questionable documentation directly with the notified body's European headquarters or through an established regulatory contact.
A PDF certificate sent by the manufacturer is evidence to investigate—not evidence to blindly accept.
3. Qualify the Authorised Representative
For a Chinese manufacturer, the authorised representative (AR) is a particularly important part of the EU regulatory structure.
The AR is legally established in the EU and has defined responsibilities under Article 11 MDR. Among other things, the AR must verify that the EU Declaration of Conformity and technical documentation have been drawn up and, where applicable, that the appropriate conformity assessment procedure has been carried out.
Therefore, do not only ask:
4. Check the Quality Management System
A manufacturer supplying medical devices to the EU should be able to demonstrate an appropriate quality management system.
In many cases, ISO 13485 certification is an important piece of evidence.
However, an ISO 13485 certificate should not be treated as proof that a specific product complies with the MDR.
The difficult question is often not whether a certificate exists, but whether the certificate is genuine, current and relevant to the actual manufacturing operation.
This is especially important when several companies are involved—for example, a brand owner, OEM manufacturer, subcontractor and separate trading company.
The legal manufacturer, certificate holder, manufacturing site and actual production site should make sense as one coherent structure.
5. Ask for representative samples and verify the actual product
Documents are necessary, but they are not enough.
The manufacturer should be able to provide representative samples of the actual device, where appropriate, to support verification of product quality and conformity.
The results should be documented and compared with the approved specifications and the applicable MDR requirements.
This is particularly important because one of the most serious qualification risks is:
The sample is not the same product as the certified product.
A physical sample may differ from the device described in the technical documentation.
A product can therefore look commercially attractive and even carry a CE mark while the actual product supplied to the European customer is not adequately represented by the regulatory documentation.
If these three do not correspond, the qualification is not complete.
6. Be very careful with private-label manufacturing
Private-label arrangements require particular attention.
If a European company places a device on the market under its own name or trademark and the MDR conditions for manufacturer responsibility are triggered, the European company may become the manufacturer under the MDR.
This is a fundamental difference from simply distributing another manufacturer's product.
The consequence can be substantial: the company taking the manufacturer role may need to assume the corresponding MDR obligations and maintain access to the required technical documentation and quality evidence.
Do not sign a private-label agreement before the regulatory role allocation is clear.
7. Outsourcing production to China: different model, similar qualification effort
Another common model is that an EU company remains the manufacturer while production is outsourced to China.
This may appear easier than private labelling, but it does not eliminate the need for a thorough qualification.
The European manufacturer remains responsible for ensuring that the device complies with the MDR.
There can nevertheless be a strategic advantage in a well-designed outsourcing model.
We have encountered manufacturers that outsource semi-finished products to China while retaining critical know-how, final assembly, testing, configuration or release activities within their own controlled system.
This can provide a useful balance between Chinese manufacturing capacity and European control of critical processes and know-how.
The key question is not simply:
"Where is the product manufactured?"
The better question is:
"Which activities are outsourced, who controls them, and how are they integrated into the manufacturer's QMS and technical documentation?"
8. Communication is part of qualification
Technical qualification can fail because of communication.
This is particularly relevant when the Chinese partner has limited English-language capability or when communication is handled mainly through sales personnel rather than regulatory and quality personnel.
We recommend establishing a structured communication process from the beginning.
For example:
Regular regulatory meetings
Use written protocols
Keep an action list
Visit the manufacturer
When working with a new Chinese partner, it is often better to learn by doing: start with a structured qualification project, test the communication process, verify samples and documentation, and gradually increase the level of cooperation.
Five practical case studies
The following examples illustrate why a certificate-based qualification approach can be misleading.
Case 1 — "We already have MDR products"
A Chinese manufacturer states that its products are MDR compliant and already available in Europe, but the claimed manufacturer/device information cannot be found consistently in EUDAMED. The claim should therefore be investigated further rather than accepted on the basis of a sales presentation or CE logo.
Case 2 — Registration exists, but the product documentation does not
A manufacturer has an EUDAMED registration and provides EU Declarations of Conformity, but some documents contain incorrect or incomplete information, while the product labelling, UDI, IFU and other conformity elements are not properly implemented. In addition, the product is not actually being distributed in the EU, raising questions about what "MDR product" means in practice.
Case 3 — Everything appears in EUDAMED, but the technical file is weak
A manufacturer has the expected EUDAMED entries and certificates, but review of the technical documentation reveals a thin technical file. The risk management documentation is insufficient, while the classification, intended purpose and technical claims are not logically consistent with each other.
Case 4 — The samples do not match the certified product
The manufacturer provides samples for evaluation, but the samples differ from the product described in the technical documentation—for example in materials, components, dimensions, software or performance. This creates a fundamental question: What exactly has been assessed and what exactly is being supplied?
Case 5 — The AR/importer has no real regulatory capability
A Chinese manufacturer has appointed an EU authorised representative or importer, but the responsible organisation has little practical MDR knowledge. Complaints, PMS and vigilance activities are poorly organised, responsibilities are unclear, and regulatory communication is reactive rather than systematic.
Conclusion: qualify the whole system, not just the CE mark
Chinese medical device manufacturers can be highly attractive partners for the European market. However, successful cooperation requires more than finding a product with a competitive price and a CE logo.
A robust qualification process should connect:
Legal manufacturer → EUDAMED → CE conformity → notified body → authorised representative → QMS → technical documentation → physical product → production → PMS/vigilance → communication.
The most important lesson is that consistency is often more important than the number of documents.
The manufacturer's identity should be consistent across the contracts, EUDAMED, certificates and labels. The device should be consistent across the sample, technical documentation, DoC, UDI, IFU and production. The responsibilities of the manufacturer, AR, importer and distributor should be consistent across the regulatory documentation and the actual working relationship.
When these elements fit together, the Chinese manufacturer can become a reliable long-term partner for the EU market.
When they do not, a CE certificate alone should never be considered sufficient qualification.
